{"id":{"repo_id":"mcmaster","oai_identifier":"oai:macsphere.mcmaster.ca:11375/11597"},"canonical_url":"https://search.ndltd.org/etd/mcmaster/oai:macsphere.mcmaster.ca:11375/11597","repository":{"repo_id":"mcmaster","name":"McMaster University","base_url":"https://macsphere.mcmaster.ca/server/oai/request"},"display":{"title":"The Effect of Goblet Cell Metaplasia On Airway Barrier Integrity","abstract":"<p><strong>Introduction</strong></p> <p>The airway epithelium, which acts as a protective barrier, is impaired in asthmatic patients and may contribute to abnormal airway function. Chronic inflammation, a feature of asthma, is associated with structural changes in the airway epithelium including the transformation of columnar epithelial cells into mucin secreting goblet cells. Human epithelial cells exposed to Interleukin-13 (IL-13) <em>in vitro</em> resulted in goblet cell metaplasia and a significant drop in transepithelial resistance, indicating that barrier function is impaired.</p> <p><strong>Aim</strong></p> <p>We sought to determine whether goblet cell metaplasia alone is sufficient to impair airway epithelial barrier function <em>in vivo</em>.</p> <p><strong>Methods</strong></p> <p>Female BALB/c mice were infected with an adenovirus to overexpress IL-13, a control adenovirus, or no virus. Barrier integrity was assessed via single-photon emission computed tomography (SPECT) imaging by measuring the dispersion of technetium-labeled diethylene triamine pentaacetic acid (<sup>99m</sup>Tc-DTPA) out of the lungs over time. Lung sections were stained by Periodic acid-Schiff to detect the presence of mucin-containing goblet cells.</p> <p><strong>Results</strong></p> <p>IL-13 exposure resulted in goblet cell metaplasia and associated airway hyperresponsiveness to methacholine. However, there was no significant increase in dispersion of <sup>99m</sup>Tc-DTPA over time from the airways in IL-13 overexpressed mice compared to control mice.</p> <p><strong>Conclusion</strong></p> <p>IL-13 induced goblet cell metaplasia did not impair the airway epithelial barrier to <sup>99m</sup>Tc-DTPA in our <em>in vivo</em> mouse model. Therefore, we conclude that epithelial dysfunction to DTPA observed in human asthmatics and in animal models of asthma are not due to IL-13 induced goblet cell metaplasia.</p>","abstract_html":"&lt;p&gt;&lt;strong&gt;Introduction&lt;/strong&gt;&lt;/p&gt; &lt;p&gt;The airway epithelium, which acts as a protective barrier, is impaired in asthmatic patients and may contribute to abnormal airway function. Chronic inflammation, a feature of asthma, is associated with structural changes in the airway epithelium including the transformation of columnar epithelial cells into mucin secreting goblet cells. Human epithelial cells exposed to Interleukin-13 (IL-13) &lt;em&gt;in vitro&lt;/em&gt; resulted in goblet cell metaplasia and a significant drop in transepithelial resistance, indicating that barrier function is impaired.&lt;/p&gt; &lt;p&gt;&lt;strong&gt;Aim&lt;/strong&gt;&lt;/p&gt; &lt;p&gt;We sought to determine whether goblet cell metaplasia alone is sufficient to impair airway epithelial barrier function &lt;em&gt;in vivo&lt;/em&gt;.&lt;/p&gt; &lt;p&gt;&lt;strong&gt;Methods&lt;/strong&gt;&lt;/p&gt; &lt;p&gt;Female BALB/c mice were infected with an adenovirus to overexpress IL-13, a control adenovirus, or no virus. Barrier integrity was assessed via single-photon emission computed tomography (SPECT) imaging by measuring the dispersion of technetium-labeled diethylene triamine pentaacetic acid (&lt;sup&gt;99m&lt;/sup&gt;Tc-DTPA) out of the lungs over time. Lung sections were stained by Periodic acid-Schiff to detect the presence of mucin-containing goblet cells.&lt;/p&gt; &lt;p&gt;&lt;strong&gt;Results&lt;/strong&gt;&lt;/p&gt; &lt;p&gt;IL-13 exposure resulted in goblet cell metaplasia and associated airway hyperresponsiveness to methacholine. However, there was no significant increase in dispersion of &lt;sup&gt;99m&lt;/sup&gt;Tc-DTPA over time from the airways in IL-13 overexpressed mice compared to control mice.&lt;/p&gt; &lt;p&gt;&lt;strong&gt;Conclusion&lt;/strong&gt;&lt;/p&gt; &lt;p&gt;IL-13 induced goblet cell metaplasia did not impair the airway epithelial barrier to &lt;sup&gt;99m&lt;/sup&gt;Tc-DTPA in our &lt;em&gt;in vivo&lt;/em&gt; mouse model. Therefore, we conclude that epithelial dysfunction to DTPA observed in human asthmatics and in animal models of asthma are not due to IL-13 induced goblet cell metaplasia.&lt;/p&gt;","abstract_has_math":false,"creators":["Dalle, Ave J Christopher"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":"Medical Sciences (Division of Physiology/Pharmacology)","school":null,"contributors":[],"advisors":["Inman, Mark D","Janssen, Luke","Jordana, Manel"],"committee_chairs":[],"committee_members":[],"year":2012,"date_issued":"2012-04","date_published":"2012-04","updated_at":"2026-11-18T19:31:14Z","subjects":["epithelial barrier","IL-13","asthma","Biological Phenomena, Cell Phenomena, and Immunity","Circulatory and Respiratory Physiology"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://doi.org/10.71548/9383"],"render_values":[{"text":"https://doi.org/10.71548/9383","href":"https://doi.org/10.71548/9383","code":true}]},{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["opendissertations/6554","7523","2345943"],"render_values":[{"text":"opendissertations/6554","href":null,"code":true},{"text":"7523","href":null,"code":true},{"text":"2345943","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/11375/11597","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"http://hdl.handle.net/11375/11597","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://macsphere.mcmaster.ca/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Amacsphere.mcmaster.ca%3A11375%2F11597","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Inman, Mark D","Janssen, Luke","Jordana, Manel"]},{"key":"dc:contributor.department","label":"Department","values":["Medical Sciences (Division of Physiology/Pharmacology)"]},{"key":"dc:creator","label":"Author","values":["Dalle, Ave J Christopher"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2014-06-18T16:55:30Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2014-06-18T16:55:30Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2011-11-11"]},{"key":"dc:date.issued","label":"Date","values":["2012-04"]},{"key":"dc:type","label":"Dc Type","values":["thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["epithelial barrier","IL-13","asthma","Biological Phenomena, Cell Phenomena, and Immunity","Circulatory and Respiratory Physiology"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["opendissertations/6554","7523","2345943"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://hdl.handle.net/11375/11597","https://doi.org/10.71548/9383"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["<p><strong>Introduction</strong></p> <p>The airway epithelium, which acts as a protective barrier, is impaired in asthmatic patients and may contribute to abnormal airway function. Chronic inflammation, a feature of asthma, is associated with structural changes in the airway epithelium including the transformation of columnar epithelial cells into mucin secreting goblet cells. Human epithelial cells exposed to Interleukin-13 (IL-13) <em>in vitro</em> resulted in goblet cell metaplasia and a significant drop in transepithelial resistance, indicating that barrier function is impaired.</p> <p><strong>Aim</strong></p> <p>We sought to determine whether goblet cell metaplasia alone is sufficient to impair airway epithelial barrier function <em>in vivo</em>.</p> <p><strong>Methods</strong></p> <p>Female BALB/c mice were infected with an adenovirus to overexpress IL-13, a control adenovirus, or no virus. Barrier integrity was assessed via single-photon emission computed tomography (SPECT) imaging by measuring the dispersion of technetium-labeled diethylene triamine pentaacetic acid (<sup>99m</sup>Tc-DTPA) out of the lungs over time. Lung sections were stained by Periodic acid-Schiff to detect the presence of mucin-containing goblet cells.</p> <p><strong>Results</strong></p> <p>IL-13 exposure resulted in goblet cell metaplasia and associated airway hyperresponsiveness to methacholine. However, there was no significant increase in dispersion of <sup>99m</sup>Tc-DTPA over time from the airways in IL-13 overexpressed mice compared to control mice.</p> <p><strong>Conclusion</strong></p> <p>IL-13 induced goblet cell metaplasia did not impair the airway epithelial barrier to <sup>99m</sup>Tc-DTPA in our <em>in vivo</em> mouse model. Therefore, we conclude that epithelial dysfunction to DTPA observed in human asthmatics and in animal models of asthma are not due to IL-13 induced goblet cell metaplasia.</p>"]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["Master of Science (MSc)"]},{"key":"dc:title","label":"Title","values":["The Effect of Goblet Cell Metaplasia On Airway Barrier Integrity"]},{"key":"others:access_status","label":"Others Access Status","values":["open.access"]}]}],"canonical_facts":{"dc:contributor.advisor":["Inman, Mark D","Janssen, Luke","Jordana, Manel"],"dc:contributor.department":["Medical Sciences (Division of Physiology/Pharmacology)"],"dc:creator":["Dalle, Ave J Christopher"],"dc:date.accessioned":["2014-06-18T16:55:30Z"],"dc:date.available":["2014-06-18T16:55:30Z"],"dc:date.created":["2011-11-11"],"dc:date.issued":["2012-04"],"dc:description.abstract":["<p><strong>Introduction</strong></p> <p>The airway epithelium, which acts as a protective barrier, is impaired in asthmatic patients and may contribute to abnormal airway function. Chronic inflammation, a feature of asthma, is associated with structural changes in the airway epithelium including the transformation of columnar epithelial cells into mucin secreting goblet cells. Human epithelial cells exposed to Interleukin-13 (IL-13) <em>in vitro</em> resulted in goblet cell metaplasia and a significant drop in transepithelial resistance, indicating that barrier function is impaired.</p> <p><strong>Aim</strong></p> <p>We sought to determine whether goblet cell metaplasia alone is sufficient to impair airway epithelial barrier function <em>in vivo</em>.</p> <p><strong>Methods</strong></p> <p>Female BALB/c mice were infected with an adenovirus to overexpress IL-13, a control adenovirus, or no virus. Barrier integrity was assessed via single-photon emission computed tomography (SPECT) imaging by measuring the dispersion of technetium-labeled diethylene triamine pentaacetic acid (<sup>99m</sup>Tc-DTPA) out of the lungs over time. Lung sections were stained by Periodic acid-Schiff to detect the presence of mucin-containing goblet cells.</p> <p><strong>Results</strong></p> <p>IL-13 exposure resulted in goblet cell metaplasia and associated airway hyperresponsiveness to methacholine. However, there was no significant increase in dispersion of <sup>99m</sup>Tc-DTPA over time from the airways in IL-13 overexpressed mice compared to control mice.</p> <p><strong>Conclusion</strong></p> <p>IL-13 induced goblet cell metaplasia did not impair the airway epithelial barrier to <sup>99m</sup>Tc-DTPA in our <em>in vivo</em> mouse model. Therefore, we conclude that epithelial dysfunction to DTPA observed in human asthmatics and in animal models of asthma are not due to IL-13 induced goblet cell metaplasia.</p>"],"dc:description.degree":["Master of Science (MSc)"],"dc:identifier.other":["opendissertations/6554","7523","2345943"],"dc:identifier.uri":["http://hdl.handle.net/11375/11597","https://doi.org/10.71548/9383"],"dc:subject":["epithelial barrier","IL-13","asthma","Biological Phenomena, Cell Phenomena, and Immunity","Circulatory and Respiratory Physiology"],"dc:title":["The Effect of Goblet Cell Metaplasia On Airway Barrier Integrity"],"dc:type":["thesis"],"others:access_status":["open.access"]},"updated_at":"2026-11-18T19:31:14Z"}